Literature DB >> 16199545

Multi-exon deletions of the PKHD1 gene cause autosomal recessive polycystic kidney disease (ARPKD).

C Bergmann1, F Küpper, C P Schmitt, U Vester, T J Neuhaus, J Senderek, K Zerres.   

Abstract

BACKGROUND: Autosomal recessive polycystic kidney disease (ARPKD) is caused by mutations in the PKHD1 (polycystic kidney and hepatic disease 1) gene on chromosome 6p12, a large gene spanning 470 kb of genomic DNA. So far, only micromutations in the 66 exons encoding the longest open reading frame (ORF) have been described, and account for about 80% of mutations.
OBJECTIVE: To test the hypothesis that gross genomic rearrangements and mutations in alternatively spliced exons contribute to a subset of the remaining disease alleles.
METHODS: Using DHPLC for alternatively spliced exons and quantitative real time polymerase chain reaction to detect genomic imbalances, 58 ARPKD patients were screened, of whom 55 were known to harbour one PKHD1 point mutation in the longest ORF.
RESULTS: Three different heterozygous PKHD1 deletions and several single nucleotide changes in alternatively spliced exons were identified. The detected partial gene deletions are most likely pathogenic, while a potential biological function of the alterations identified in alternatively spliced exons must await the definition of transcripts containing alternative exons and their predicted reading frames.
CONCLUSIONS: Gross PKHD1 deletions account for a detectable proportion of ARPKD cases. Screening for major genomic PKHD1 rearrangements will further improve mutation analysis in ARPKD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199545      PMCID: PMC1735935          DOI: 10.1136/jmg.2005.032318

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  16 in total

1.  Comprehensive genetic testing in children with a clinical diagnosis of ARPKD identifies phenocopies.

Authors:  Tamás Szabó; Petronella Orosz; Eszter Balogh; Eszter Jávorszky; István Máttyus; Csaba Bereczki; Zoltán Maróti; Tibor Kalmár; Attila J Szabó; George Reusz; Ildikó Várkonyi; Erzsébet Marián; Éva Gombos; Orsolya Orosz; László Madar; György Balla; János Kappelmayer; Kálmán Tory; István Balogh
Journal:  Pediatr Nephrol       Date:  2018-06-28       Impact factor: 3.714

Review 2.  Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease.

Authors:  Carsten Bergmann; Valeska Frank; Fabian Küpper; Dirk Kamitz; Jens Hanten; Peter Berges; Silke Mager; Markus Moser; Jutta Kirfel; Reinhard Büttner; Jan Senderek; Klaus Zerres
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  A 7-year-old girl with renal medullary hyperechogenicity and hypertension: Answers.

Authors:  İlknur Girişgen; Selcuk Yüksel; Furkan Ufuk; Taner Durak; Tülay Becerir
Journal:  Pediatr Nephrol       Date:  2021-10-11       Impact factor: 3.714

4.  Targeted genome-wide enrichment of functional regions.

Authors:  Periannan Senapathy; Ashwini Bhasi; Jeffrey Mattox; Perundurai S Dhandapany; Sakthivel Sadayappan
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

5.  Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.

Authors:  Wybrich R Cnossen; Jake S F Maurits; Jody Salomon; René H M Te Morsche; Esmé Waanders; Joost P H Drenth
Journal:  J Clin Lab Anal       Date:  2015-09-13       Impact factor: 2.352

Review 6.  Cholangiociliopathies: genetics, molecular mechanisms and potential therapies.

Authors:  Tatyana Masyuk; Anatoliy Masyuk; Nicholas LaRusso
Journal:  Curr Opin Gastroenterol       Date:  2009-05       Impact factor: 3.287

7.  Cost-effective PKHD1 genetic testing for autosomal recessive polycystic kidney disease.

Authors:  Paola Krall; Cristina Pineda; Patricia Ruiz; Laia Ejarque; Teresa Vendrell; Juan Antonio Camacho; Santiago Mendizábal; Artur Oliver; José Ballarín; Roser Torra; Elisabet Ars
Journal:  Pediatr Nephrol       Date:  2013-10-27       Impact factor: 3.714

8.  Expanding the mutation spectrum in 130 probands with ARPKD: identification of 62 novel PKHD1 mutations by sanger sequencing and MLPA analysis.

Authors:  Salvatore Melchionda; Teresa Palladino; Stefano Castellana; Mario Giordano; Elisa Benetti; Patrizia De Bonis; Leopoldo Zelante; Luigi Bisceglia
Journal:  J Hum Genet       Date:  2016-05-26       Impact factor: 3.172

9.  PKHD1 sequence variations in 78 children and adults with autosomal recessive polycystic kidney disease and congenital hepatic fibrosis.

Authors:  Meral Gunay-Aygun; Maya Tuchman; Esperanza Font-Montgomery; Linda Lukose; Hailey Edwards; Angelica Garcia; Surasawadee Ausavarat; Shira G Ziegler; Katie Piwnica-Worms; Joy Bryant; Isa Bernardini; Roxanne Fischer; Marjan Huizing; Lisa Guay-Woodford; William A Gahl
Journal:  Mol Genet Metab       Date:  2009-10-20       Impact factor: 4.797

10.  Deletion of GPIHBP1 causing severe chylomicronemia.

Authors:  Jonathan J Rios; Savitha Shastry; Juan Jasso; Natalie Hauser; Abhimanyu Garg; André Bensadoun; Jonathan C Cohen; Helen H Hobbs
Journal:  J Inherit Metab Dis       Date:  2011-10-19       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.